Cargando…
Respiratory syncytial virus: promising progress against a leading cause of pneumonia
Autores principales: | Ginsburg, Amy Sarah, Srikantiah, Padmini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585487/ https://www.ncbi.nlm.nih.gov/pubmed/34774184 http://dx.doi.org/10.1016/S2214-109X(21)00455-1 |
Ejemplares similares
-
Integrated pneumonia surveillance: pandemics and beyond
por: Ginsburg, Amy Sarah, et al.
Publicado: (2022) -
Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in Low- and Middle-Income Countries: The Importance of Community Mortality Studies
por: Srikantiah, Padmini, et al.
Publicado: (2021) -
COVID-19 pneumonia and the appropriate use of antibiotics
por: Ginsburg, Amy Sarah, et al.
Publicado: (2020) -
Universal infant immunisation against respiratory syncytial virus and European inequalities: the pandemics lesson has not been learnt
por: De Luca, Daniele, et al.
Publicado: (2023) -
New respiratory syncytial virus immunization products in low- and middle-income countries: potential for cost-effective impact on a high burden of disease in young infants
por: Srikantiah, Padmini, et al.
Publicado: (2023)